Omeros Corp reports results for the quarter ended June 30 - Earnings Summary

• Omeros Corp OMER.OQ reported a quarterly adjusted loss of 43 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -97 cents. The mean expectation of four analysts for the quarter was for a loss of 48 cents per share. Wall Street expected results to range from -64 cents to -39 cents per share.

• Reported revenue was zero​; analysts expected $312.50 thousand.

• Omeros Corp's reported EPS for the quarter was a loss of 43 cents​.

• The company reported a quarterly loss of $25.42 million.

• Omeros Corp shares had risen by 42.3% this quarter and lost 56.8% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 5.7% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Omeros Corp is $36.00, about 88.1% above its last closing price of $4.27

This summary was machine generated from LSEG data August 14 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)